About us

A+ Science is a complete clinical service CRO with long experience of services in clinical trials for pharmaceuticals (Phase I-IV) as well as medical devices. We also have experience in conducting non-interventional and registry trials.

Our services are within clinical trial management, outsourcing of consultants, pharmacovigilance and Site Management Organisation (SMO) with investigators and research nurses based in Stockholm.

We have experience since 1997 and work in broad spectra of therapeutic areas in the Nordic countries as well as Northern Europe. Our staff is familiar with responsibilities within project management and monitoring which could range from small complex to multicenter trials.

Through close cooperation and continuous dialogue with customers, our services can be customised according to your requirements. By being flexible we can provide a complete solution or support within specific areas and activities.

Among our customers are pharmaceuticals, generic, biotech and medical device companies, as well as Clinical Research Organisations (CROs) located in Sweden, Europe and USA.

Through medical expertise, critical knowledge and many years of experience we can offer cost-effective services during clinical development as well as services after marketing authorisation.

A+ Science is member of SwedenBIO, Medicon Valley Alliance (MVA),  ASCRO and LIF.

Since December 2013, A+ Science is a CRO run by its employees. Our vision is to become the CRO best known for its unique and dedicated personnel with focus on customer satisfaction. To Earn Trust - Make Difference

What is a clinical CRO?

A Clinical CRO (Contract Research Organisation) is a service organisation that provides support to the pharmaceutical and biotech industry as well as medical devices. CROs contribute to the development of new medicines that improve health and quality of life for patients. That work is mostly summarised in an activity called clinical trials.

Clinical Trials

Clinical trials are used to determine the safety and efficacy of new treatments in patients. The new treatment is tested in several stages and must be beneficial for patients to be accepted and marketed. A clinical trial cannot start without the approval of independent ethics committees and competent authorities.